Most cited papers in Neuroendocrine Tumor Research Advances
What are the most cited papers in Neuroendocrine Tumor Research Advances?
The most cited paper in Neuroendocrine Tumor Research Advances is "Modulating Innate and Adaptive Immunity by (R)-Roscovitine: Potential Therapeutic Opportunity in Cystic Fibrosis" (Laurent Meijer et al., 2016), with 4,999 citations. Next come "One Hundred Years After “Carcinoid”: Epidemiology of and Prognostic Factors for Neuroendocrine Tumors in 35,825 Cases in the United States" (4,565) and "Immune Checkpoint Blockade: A Common Denominator Approach to Cancer Therapy" (4,339).
Showing 50 of 99 papers. Every paper with more than 967 citations is listed.
| # | Paper | ||
|---|---|---|---|
| 1 | Modulating Innate and Adaptive Immunity by (R)-Roscovitine: Potential Therapeutic Opportunity in Cystic Fibrosis Laurent Meijer et al. · Journal of Innate Immunity | 2016 | 4,999 |
| 2 | One Hundred Years After “Carcinoid”: Epidemiology of and Prognostic Factors for Neuroendocrine Tumors in 35,825 Cases in the United States James C. Yao, Manal M. Hassan, Alexandria T. Phan et al. · Journal of Clinical Oncology | 18 Jun 2008 | 4,565 |
| 3 | Immune Checkpoint Blockade: A Common Denominator Approach to Cancer Therapy Suzanne Louise Topalian, Charles G. Drake, Drew M. Pardoll · Cancer Cell | Apr 2015 | 4,339 |
| 4 | Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline Julie Renee Brahmer et al. · Journal of Clinical Oncology | 14 Feb 2018 | 3,766 |
| 5 | Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States Arvind N. Dasari, Chan Shen, Daniel M. Halperin et al. · JAMA Oncology | 27 Apr 2017 | 3,531 |
| 6 | Phase 3 Trial of 177 Lu-Dotatate for Midgut Neuroendocrine Tumors Jonathan Strosberg et al. · New England Journal of Medicine | 11 Jan 2017 | 3,307 |
| 7 | Everolimus for Advanced Pancreatic Neuroendocrine Tumors James C. Yao, Manisha H. Shah, Tetsuhide Ito et al. · New England Journal of Medicine | 9 Feb 2011 | 2,877 |
| 8 | A 5‐decade analysis of 13,715 carcinoid tumors Irvin Mark Modlin, Kevin D. Lye, Mark S. Kidd · Cancer | 3 Feb 2003 | 2,758 |
| 9 | IgG4-Related Disease John H. Stone, Yoh Zen, Vikram Deshpande · New England Journal of Medicine | 8 Feb 2012 | 2,629 |
| 10 | Consensus statement on the pathology of IgG4-related disease Vikram Deshpande et al. · Modern Pathology | 18 May 2012 | 2,616 |
| 11 | Pancreatic Cancer Manuel M. Hidalgo · New England Journal of Medicine | 28 Apr 2010 | 2,593 |
| 12 | Sunitinib Malate for the Treatment of Pancreatic Neuroendocrine Tumors Éric Raymond, Laëtitia Dahan, Jean‐Luc Raoul et al. · New England Journal of Medicine | 9 Feb 2011 | 2,567 |
| 13 | Placebo-Controlled, Double-Blind, Prospective, Randomized Study on the Effect of Octreotide LAR in the Control of Tumor Growth in Patients With Metastatic Neuroendocrine Midgut Tumors: A Report From the PROMID Study Group Anja Rinke, Hans‐Helge Müller, Carmen Schade‐Brittinger et al. · Journal of Clinical Oncology | 24 Aug 2009 | 2,525 |
| 14 | Cyclic AMP stimulates somatostatin gene transcription by phosphorylation of CREB at serine 133 Gustavo A. Romero González, Marc Montminy · Cell | Nov 1989 | 2,514 |
| 15 | Epidemiology of Pancreatic Cancer: Global Trends, Etiology and Risk Factors Prashanth Rawla, Tagore Sunkara, Vinaya V. Gaduputi · World Journal of Oncology | 2019 | 2,345 |
| 16 | Durvalumab plus platinum–etoposide versus platinum–etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial Luis G Paz-Ares et al. · The Lancet | 4 Oct 2019 | 2,310 |
| 17 | Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes Concepción Almoguera, Darryl K. Shibata, Kathleen Forrester et al. · Cell | May 1988 | 2,123 |
| 18 | Positional Cloning of the Gene for Multiple Endocrine Neoplasia-Type 1 Settara C. Chandrasekharappa et al. · Science | 18 Apr 1997 | 2,099 |
| 19 | Subtypes of pancreatic ductal adenocarcinoma and their differing responses to therapy Eric Andrew Collisson, Anguraj Sadanandam, Peter Olson et al. · Nature Medicine | Apr 2011 | 2,060 |
| 20 | Pancreatic cancer: A review of clinical diagnosis, epidemiology, treatment and outcomes Andrew J. McGuigan, Paul J Kelly, Richard Calvin Turkington et al. · World Journal of Gastroenterology | 20 Nov 2018 | 2,012 |
| 21 | European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium Furio Pacini, Martin Jean Schlumberger, Henning Dralle et al. · European Journal of Endocrinology | 25 May 2006 | 1,986 |
| 22 | Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A Lois M. Mulligan, John B. Kwok, Catherine S. Healey et al. · Nature | Jun 1993 | 1,975 |
| 23 | Lanreotide in Metastatic Enteropancreatic Neuroendocrine Tumors Martyn Evan Caplin, Marianne Ellen Pavel, Jarosław Bogdan Ćwikła et al. · New England Journal of Medicine | 11 Jul 2014 | 1,954 |
| 24 | GLUCAGON-LIKE PEPTIDE-1 7-36: A PHYSIOLOGICAL INCRETIN IN MAN Bernhard Kreymann, Mohammad A. Ghatei, Gareth Williams et al. · The Lancet | Dec 1987 | 1,937 |
| 25 | CONSENSUS: Guidelines for Diagnosis and Therapy of MEN Type 1 and Type 2 Maria Luisa Brandi et al. · The Journal of Clinical Endocrinology & Metabolism | Dec 2001 | 1,917 |
| 26 | Gastroenteropancreatic neuroendocrine tumours Irvin Mark Modlin, Kjell Öberg, Daniel C. Chung et al. · The Lancet Oncology | 2008 | 1,768 |
| 27 | DAXX / ATRX , MEN1 , and mTOR Pathway Genes Are Frequently Altered in Pancreatic Neuroendocrine Tumors Yuchen Jiao, Chanjuan Shi, Barish H. Edil et al. · Science | 20 Jan 2011 | 1,727 |
| 28 | Pancreatic cancer Donghui Li, Keping Xie, Robert A. Wolff et al. · The Lancet | Mar 2004 | 1,724 |
| 29 | Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011 Hisanori Umehara et al. · Modern Rheumatology | 4 Jan 2012 | 1,661 |
| 30 | Somatostatin and Its Receptor Family Yogesh Patel · Frontiers in Neuroendocrinology | Jul 1999 | 1,653 |
| 31 | Small-cell lung cancer Charles M. Rudin, Elisabeth M. Brambilla, Corinne Faivre Finn et al. · Nature Reviews Disease Primers | 14 Jan 2021 | 1,632 |
| 32 | Extrapulmonary Inflammatory Myofibroblastic Tumor (Inflammatory Pseudotumor) A Clinicopathologic and Immunohistochemical Study of 84 Cases Cheryl M. Coffin, Jan Watterson, John R. Priest et al. · The American Journal of Surgical Pathology | Aug 1995 | 1,593 |
| 33 | TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system Guido Rindi, G. Klöppel, H. Alhman et al. · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin | 11 Sep 2006 | 1,574 |
| 34 | Somatostatin receptor scintigraphy with [111In-DTPA-d-Phe1]- and [123I-Tyr3]-octreotide: the Rotterdam experience with more than 1000 patients E. P. Krenning, Dik J. Kwekkeboom, Willem H. Bakker et al. · European Journal of Nuclear Medicine and Molecular Imaging | Aug 1993 | 1,572 |
| 35 | A clinicopathologic analysis of adriamycin cardiotoxicity Edward A. Lefrak, Jan V Pitha, Sidney Rosenheim et al. · Cancer | Aug 1973 | 1,566 |
| 36 | Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism Paul Ursmar Milliez, Xavier J. Girerd, Pierre‐François Plouin et al. · Journal of the American College of Cardiology | Apr 2005 | 1,543 |
| 37 | Twice-Daily Compared with Once-Daily Thoracic Radiotherapy in Limited Small-Cell Lung Cancer Treated Concurrently with Cisplatin and Etoposide Andrew T. Turrisi, KyungMann Kim, Ronald H. Blum et al. · New England Journal of Medicine | 28 Jan 1999 | 1,516 |
| 38 | The Thyroid Nodule László Dávid Hegedűs · New England Journal of Medicine | 20 Oct 2004 | 1,502 |
| 39 | Resected adenocarcinoma of the pancreas—616 patients: results, outcomes, and prognostic indicators Taylor A. Sohn, Charles J. Yeo, John L. Cameron et al. · Journal of Gastrointestinal Surgery | Nov 2000 | 1,495 |
| 40 | 1423 Pancreaticoduodenectomies for Pancreatic Cancer: A Single-Institution Experience Jordan Michael Winter, John L. Cameron, Kurtis A. Campbell et al. · Journal of Gastrointestinal Surgery | Nov 2006 | 1,492 |
| 41 | Clinical Practice Guidelines for Multiple Endocrine Neoplasia Type 1 (MEN1) Rajesh V. Thakker, Paul J. Newey, Gerard V. Walls et al. · The Journal of Clinical Endocrinology & Metabolism | 22 Jun 2012 | 1,484 |
| 42 | A new clinicopathological entity of IgG4-related autoimmune disease Terumi Kamisawa, Nobuaki Funata, Yukiko K Hayashi et al. · Journal of Gastroenterology | Oct 2003 | 1,470 |
| 43 | Neuroblastoma Katherine K. Matthay, John M. Maris, Gudrun Schleiermacher et al. · Nature Reviews Disease Primers | 10 Nov 2016 | 1,469 |
| 44 | Treatment With the Radiolabeled Somatostatin Analog [ 177 Lu-DOTA 0 ,Tyr 3 ]Octreotate: Toxicity, Efficacy, and Survival Dik J. Kwekkeboom, Wouter W. de Herder, Boen L.R. Kam et al. · Journal of Clinical Oncology | 29 Apr 2008 | 1,459 |
| 45 | Cells of origin in cancer Jane E. Visvader · Nature | 2011 | 1,451 |
| 46 | Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): A consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis Morie Abraham Gertz, Ray Comenzo, Rodney H. Falk et al. · American Journal of Hematology | 2005 | 1,438 |
| 47 | Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer Martin Peifer et al. · Nature Genetics | 2 Sep 2012 | 1,435 |
| 48 | Identification of a cyclic-AMP-responsive element within the rat somatostatin gene. Marc Montminy, Kevin A. Sevarino, John A. Wagner et al. · Proceedings of the National Academy of Sciences | Sep 1986 | 1,425 |
| 49 | Binding of a nuclear protein to the cyclic-AMP response element of the somatostatin gene Marc Montminy, Louise M. Bilezikjian · Nature | Jul 1987 | 1,401 |
| 50 | ENETS Consensus Guidelines Update for the Management of Patients with Functional Pancreatic Neuroendocrine Tumors and Non-Functional Pancreatic Neuroendocrine Tumors Massimo Falconi, Barbro K. Eriksson, Gregory Kaltsas et al. · Neuroendocrinology | 2016 | 1,376 |
Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for a field when OpenAlex files it under one of the field's topics; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.